Cloverleaf Bio

Business Services · United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Research & Development

About Cloverleaf Bio

Cloverleaf Bio is focused on developing a novel class of RNA therapeutics aimed at enhancing patient outcomes in oncology. Their innovative platform utilizes engineered tRNA therapeutics to directly inhibit multiple enzymes critical for cancer growth from a single therapeutic molecule. The company is led by a team of experienced co-founders, including experts in the field of RNA technology. Cloverleaf Bio's primary clients are likely to be healthcare providers and organizations involved in cancer treatment and research.Explore more
Cloverleaf Bio's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Cloverleaf Bio Org Chart

Austin Draycott, Co-Founder & Chief Executive Officer at Cloverleaf Bio
United States flag for contact location.

Co-Founder & Chief Executive Officer

PhoneEmail
Cole Lewis, Co-Founder & Chief Scientific Officer at Cloverleaf Bio
United States flag for contact location.

Co-Founder & Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
Illustration of an envelope

Top Business Services Companies

Frequently Asked Questions Regarding Cloverleaf Bio

What is Cloverleaf Bio's official website?
Cloverleaf Bio's official website is www.cloverleafbio.com
What is Cloverleaf Bio's Revenue?
Cloverleaf Bio's revenue is <$5 Million
What is Cloverleaf Bio's SIC code?
Cloverleaf Bio's SIC: 28,283
What is Cloverleaf Bio's NAICS code?
Cloverleaf Bio's NAICS: 32,325
How many employees does Cloverleaf Bio have?
Cloverleaf Bio has 1-10 employees
What industry does Cloverleaf Bio belong to?
Cloverleaf Bio is in the industry of: Business Services, Research & Development
What does Cloverleaf Bio do?

Cloverleaf Bio is focused on developing a novel class of RNA therapeutics aimed at enhancing patient outcomes in oncology. Their innovative platform utilizes engineered tRNA therapeutics to directly inhibit multiple enzymes critical for cancer growth from a single therapeutic molecule. The company is led by a team of experienced co-founders, includ... ing experts in the field of RNA technology. Cloverleaf Bio's primary clients are likely to be healthcare providers and organizations involved in cancer treatment and research.Read More

What are Cloverleaf Bio social media links?
Cloverleaf Bio Linkedin page
Who invested in Cloverleaf Bio?
Cloverleaf Bio has 5 investors including Mission BioCapital, AbbVie, Lilly and Draper Associates.
Is Cloverleaf Bio a public company?
Cloverleaf Bio is private company therefore does not currently have an official ticker symbol
See more information about Cloverleaf Bio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.